Varanasi (UP) - A study conducted by the Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University (IMS-BHU), has found that Ayurvedic medicines started giving relief to around 4000 patients suffering from various common diseases within three days and 8000 patients within seven days.
The Faculty of Ayurveda conducted the study to assess the impact of Ayurvedic medicines on 13,936 patients in eight government Ayurvedic college hospitals and certain dispensaries across the state between June 2022 and February 2023.
"The patients suffering from fever, cough, cold, high blood pressure, diabetes, arthritis, jaundice, and other common diseases were surveyed to assess the impact of Ayurvedic medicines on them," said Vaidya Sushil Kumar Dubey, professor, Faculty of Ayurveda, BHU.
Dubey along with former dean of the faculty Prof Yamini Bhushan Tripathi had planned the study in April 2022.
The vaidyas (Ayurveda practitioners) gave medicines to the patients and recorded their impact on them when they visited hospitals for follow-up after a week. (Agency)
Read More►Sarbananda Sonowal Inaugurates Six New Buildings of the North Eastern Institute of Ayurveda
Fifatrol, an ayurvedic formulation composed of time-tested herbs, is effective in treatment of upper respiratory tract infections (URTI), a contagious viral and bacterial infection, according to a study published in the International Research Journal of Ayurveda and Yoga.
A team of researchers had carried out the study on 203 patients with URTI in various health centres across the country.
During the treatment, the health parameters of the patients, who were given Fifatrol twice a day, were checked on the first, fourth and seventh day.
As per the study, the patient's condition was found to be improved by 69.5 per cent and 90.36 per cent within the fourth and seventh days respectively.
"Effectiveness was evaluated by examining the reduction in symptoms scores at day four and seven respectively. This observational study has gathered evidence about the effectiveness and safety of Fifatrol on the amelioration of the symptoms of URTI," said the authors.
The researchers also did not find any adverse impact of the formulations on the patients.
Fifatrol has not only been found to be effective in treating URTI but also well accepted by the physicians of Ayurveda for the successful management of conditions like flu and associated symptoms like fever, nasal congestion, running nose, etc, it added.
In fact, Fifatrol as an immunity-boosting ayurvedic drug has found a mention as Covid-19 combating formulation in the 'Compendium of Indian Technologies for Combating COVID-19 (Tracing, Testing &Treating)', compiled by the state-run National Research Development Corporation last year, AIMIL Pharma Executive Director Sanchit Sharma said. Normally, the ayurvedic medicines have been seen as supplements to increase immunity, he added.
However, the government has been taking several steps to boost the Ayurveda sector. There has been compelling evidence that medicinal herbs can be a first line of defense against infectious diseases.
No wonder, being a rich combination of five vital classical formulations like Tribhuvan Kirti Rasa, Mrtunjay Rasa and Sanjivani Vati with extracts from herbs like Guduchi, Daruharidra, Chirayata, Kutaki, Tulsi, Apamarga and Karanja, Fifatrol improves the immune system to fight against viruses and other infections, eases the associated symptoms and fastens the recovery, underlined the study.
It also helps fast relief from nasal congestion, body ache, sore throat, and headache, it said.
The study on effectiveness of the Ayurveda formulation holds importance given that usually, to treat the infection which is common during winters, people resort directly to antibiotics.
It has a huge economic burden as well as high as USD 22 billion a year, leaving a hole in the pocket of the patients.
URTI accounts for around 10 million outpatient consultations in a year especially because of the severity of its symptoms.
There is a small, but growing, subset of livers that have been transplanted and have a cumulative age of more than 100 years, researchers said.
The researchers said they studied these livers to identify characteristics to determine why these organs are so resilient, paving the way for considering the potential expanded use of older liver donors.
"Livers are incredibly resilient organs," said lead study author Yash Kadakia from the University of Texas (UT) Southwestern Medical Center, Dallas.
"We are using older donors, we have better surgical techniques, we have advances in immunosuppression, and we have better matching of donor and recipient factors. All these things allow us to have better outcomes," Kadakia added.
For the study, presented their findings at the Scientific Forum of the American College of Surgeons (ACS) Clinical Congress 2022, the team used the United Network for Organ Sharing (UNOS) STARfile to identify livers that had a cumulative age (total initial age at transplant plus post-transplant survival) of at least 100 years.
Of 253,406 livers transplanted between 1990-2022, 25 livers met the criteria of being centurion livers those with a cumulative age over 100 years.
"We looked at pre-transplant survival essentially, the donor's age as well as how long the liver went on to survive in the recipient," said Kadakia.
"We stratified out these remarkable livers with over 100-year survival and identified donor factors, recipient factors, and transplant factors involved in creating this unique combination where the liver was able to live to 100 years," Kadakia added.
For these centurion livers, the average donor age was significantly higher, 84.7 years, compared with 38.5 years for non-centurion liver transplants.
The researchers noted that for a liver to make it to 100, they expected to find an older average donor age and healthier donors. Notably, the donors from the centurion group had a lower incidence of diabetes and fewer donor infections.
Read More► Ultrasound Can Move, Break Up Kidney Stones in Awake Patients: Study
A simple ultrasound technique can be used to move, reposition or break up kidney stones, all while the patient is awake, a new study has revealed.
The technique combines the use of two ultrasound technologies to offer an option to move kidney stones out of the ureter with minimal pain and no anaesthesia, according to doctors from University of Washington School of Medicine (UW Medicine).
In the procedure, the physician uses a handheld transducer placed on the skin to direct ultrasound waves towards the stone.
The ultrasound can then be used to move and reposition the stones to promote their passage, a process called ultrasound propulsion, or to break up the stone, a technique called burst wave lithotripsy (BWL).
Unlike shock wave lithotripsy, which is the standard procedure now in use and requires sedation, this technology doesn't hurt, said lead author Dr M Kennedy Hall, an emergency medicine doctor at UW Medicine.
"It's nearly painless, and you can do it while the patient is awake, and without sedation, which is critical," Hall said.
The research team hopes that, with this new technology, the procedure of moving or breaking up the stones could eventually be performed in a clinic or emergency room setting.
Stones in the ureter, which leads from the kidney to the bladder, can cause severe pain and are a common reason for emergency department visits.
Most patients with ureteral stones are advised to wait to see if the stone will pass on its own.
However, this observation period can last for weeks, with nearly one-fourth of patients eventually requiring surgery, Hall noted.
Twenty-nine patients participated in the new study. Sixteen were treated with propulsion alone and 13 with propulsion and burst wave lithotripsy. In 19 patients, the stones moved.
In two cases, the stones moved out of the ureter and into the bladder.
Burst wave lithotripsy fragmented the stones in seven of the cases. At a two-week follow up, 18 of 21 patients (86 per cent) whose stones were located lower in the ureter, closer to the bladder, had passed their stones.
In this group, the average time to stone passage was about four days, the study noted.
One of these patients felt "immediate relief" when the stone was dislodged from the ureter, the study stated.
Read More► Experts Make A Case for Continued Mask Use
A team of doctors from premier health research institute All India Institute of Medical Sciences (AIIMS) here has found that anti-diabetic ayurvedic drug BGR-34 is effective in cutting down obesity along with improving metabolism mechanisms of the patient afflicted with the chronic disease.
Led by Sudhir Chandra Sarangi, Additional Professor, Department of Pharmacology AIIMS, the team reached this conclusion following a study spanning three years.
Comprising a range of ingredients from medicinal plants, this drug has been developed after an intensive research by the Council for Scientific and Industrial Research (CSIR) and is being marketed by the AIMIL Pharmaceuticals.
The study was aimed to investigate whether BGR-34 was effective on its own or along with other allopathy drugs and if yes then at what level.
The results were encouraging. It found that the herbal drug was enough not only in reduction of fasting blood sugar through modulation of hormonal profile along with a significant body weight reduction but there were other benefits also.
The drug also modulates hormonal profile, lipid profile and triglyceride level while bringing down leptin mark which is effective in controlling fat.
Triglyceride in excess quantity is harmful for the health as it is a bad cholesterol.
Similarly, controlled lipid profile keeps heart diseases at bay while disturbance in hormonal profile can result in poor sleep, noted the authors about the research based on various health parameters.
In contrast, modulation of hormonal profile was found to be significant, resulting in increased insulin level.
The study initiated in March 2019 will soon be published in a research journal.
Sanchit Sharma, Executive Director of AIMIL Pharmaceutical, said that herbal-based ayurveda medicines are finding huge acceptance among people who are more keen into taking preventive health measures in the backdrop of rising non communicable diseases due to lifestyle changes among others.
"To cater to this increasing demand, the government too has taken various measures to boost the availability of these products based on time-tested medicinal plants as immunity boosters," he added.
In fact, yet another study published in the latest edition of Serbian Journal of Experimental and Clinical Research on Sciendo scientific platform has found that BGR-34 can help lower sugar level within three months and also exert a powerful antioxidant action to prevent complications of the diabetes which is on the increase in the country.
Also, Read in hindi► आयुर्वेदिक दवा बीजीआर-34 मोटापे और मधुमेह में प्रभावी - एम्स स्टडी
A sudden seasonal flu outbreak and an increase in Covid-19 cases have surprised many just as we were beginning to get used to the normalcy of a life without many constraints before the Covid virus.
An unavoidable flu wave generally coincides with a change in season. However, this season has witnessed an unanticipated increase in such cases-nearly doubling from last year in some areas-as well as harsher, Covid-like symptoms.
The spike of Covid-19 cases, the upcoming holiday season, and all of this together create a situation that specialists warn calls for ongoing precautions.
"Masks are the first line of defence against Covid-19 as well as other respiratory infections. With a spike in the number of infections, we must adhere to wearing masks when we step out in public areas. With the festive season right here and large gatherings inevitable, wearing masks are highly effective at reducing your risk of getting Covid as well as seasonal flu. Wearing the right kind of mask, the right way, is also extremely important," says Dr SC Ajmani, General Physician.
Your masks' kind and fit have a significant impact on how effective they are. According to research conducted by the Max Planck Institute for Dynamics and Self Organization in Germany, FFP2 masks that fit snugly offer 75 times more protection than surgical masks. By selecting these masks over common surgical or fabric masks, you greatly boost your protection and can leave the house more confidently, especially in crowded areas.
Protection from viruses, bacteria, dust, pollutants, allergens, and pollen (>= 0.3 micron) is offered by a BIS-approved FFP2 S mask like Savlon. These masks offer 95% protection from aerosols with particles larger than 0.3 micron. In comparison to standard masks, these masks include melt blown filters that are electro statically charged to provide enhanced filtering. The comfort and suitability of these masks for different skin types are also tested. Masks made with Savlon FFP2 S are BIS Certified.
According to BIS guidelines, each batch is put through rigorous testing for quality performance and efficacy. The effects of viruses, bacteria, dust, pollution, pollen, and allergies can be significantly minimised and the wearer's general health can be improved by donning a high-quality, properly fitted mask.
The correct masks are adjusted to perfectly fit on the bridge of your nose and to properly enclose your mouth and nose. We are aware that when an infected individual sneezes or coughs in a crowded environment, the Covid-19 virus as well as the seasonal influenza can spread quickly. First-level protection is unquestionably provided by donning a N95 or FFP2 S mask, especially for those with allergies, co-morbidities, impaired immune systems, or a higher propensity for experiencing severe symptoms.
The use of masks should become a way of life. We must continue using tried-and-true health strategies, like using masks in public. Keep your hygiene and health in mind.
Read More► Intermittent Fasting May Reduce Complications From Covid-19: Study
Dear Patron, Please provide additional information to validate your profile and continue to participate in engagement activities and purchase medicine.